CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy (original) (raw)

An investigation of the control of cell division and quiescence in leukaemic versus normal haemopoietic stem and progenitor cells

Mhairi Copland

11017

CS - Paul O'Gorman Leukaemia Research Centre

Targeting p53, cMyc and PRC2 regulatory hubs: A systematic and stratified approach to deliver new therapeutics for CML

David Vetrie

14033

CS - Paul O'Gorman Leukaemia Research Centre

The importance of the Notch pathway and its interaction in the maintenance and progression of chronic myeloid leukaemia

Mhairi Copland

100626/Z/12/Z

CS - Paul O'Gorman Leukaemia Research Centre

Self-renewal pathway manipulation as a potential\r\ntherapeutic strategy for the eradication of Chronic Myeloid Leukaemia (CML)\r\nStem Cells

David Irvine

CAF/08/09

CS - Paul O'Gorman Leukaemia Research Centre

Development of a flow cytometry service within the Paul O'Gorman Leukaemia Research Centre

Alison Michie

KKL501

CS - Paul O'Gorman Leukaemia Research Centre